PHOENIX--(BUSINESS WIRE)--OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, has extended its intellectual property (IP) portfolio to include an exclusive option to license IP ...
New research explores the spillover of myxoma virus from European rabbits to Iberian hares. In addition to shedding new light on species-jumping viruses, the study shows that the protein permitting ...
Biologists have found a molecular explanation for myxoma virus/rabbit coevolution in Australia. The study of myxoma virus — related to the smallpox virus — may give insight to pathogen evolution. A ...
Odontogenic myxoma is an uncommon, benign neoplasm of odontogenic origin that presents a unique challenge owing to its locally aggressive behaviour and propensity for recurrence. The tumour arises ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback